<code id='CBDD656658'></code><style id='CBDD656658'></style>
    • <acronym id='CBDD656658'></acronym>
      <center id='CBDD656658'><center id='CBDD656658'><tfoot id='CBDD656658'></tfoot></center><abbr id='CBDD656658'><dir id='CBDD656658'><tfoot id='CBDD656658'></tfoot><noframes id='CBDD656658'>

    • <optgroup id='CBDD656658'><strike id='CBDD656658'><sup id='CBDD656658'></sup></strike><code id='CBDD656658'></code></optgroup>
        1. <b id='CBDD656658'><label id='CBDD656658'><select id='CBDD656658'><dt id='CBDD656658'><span id='CBDD656658'></span></dt></select></label></b><u id='CBDD656658'></u>
          <i id='CBDD656658'><strike id='CBDD656658'><tt id='CBDD656658'><pre id='CBDD656658'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:63
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Report captures long Covid’s disabling effects and policy challenges
          Report captures long Covid’s disabling effects and policy challenges

          RidinganearlyemptyStatenIslandferryearlyinthepandemicin2020.SpencerPlatt/GettyImagesTheCovidpandemic

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          A biotech analyst on neuroscience, placebo effect, not over

          PaulMatteis(right),in2017withthen-colleaguesSeamusFernandez(farleft)GeoffreyPorges.AlexHogan/STATNEW